gemeprost Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Gemeprost (16, 16-dimethyl-trans-delta2 PGE1 methyl ester) is an analogue of prostaglandin E1.   Wikipedia

Chemistry

  • SMILES: CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC
  • InChIKey: KYBOHGVERHWSSV-VNIVIJDLSA-N
  • Mol. Mass: 394.55
  • ALogP: 3.98
  • ChEMBL Molecule:
    gemeprost  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

16,16-dimethyl-delta(2)-pge1 methyl ester | 16,16-dimethyl-delta(2)-prostaglandin e1 methyl ester | 16,16-dimethyl-trans-delta-2-pge1 methyl ester | 16,16-dimethyl-trans-delta(2)-pge(1) methyl ester | 16,16-dimethyl-trans-delta(2)-prostaglandin e(1) methyl ester | 16,16-dimethyl-trans-delta(sup 2)-prostaglandin e1 methyl ester | 16,16-dmtdpgeme | (2e,11 alpha,13e,15r)-11,15-dihydroxy-16,16- dimethyl-9-oxoprosta-2,13-dien-1-oic acid, methyl ester | aventis brand of gemeprost | carprost | cergem | cervagem | cervageme | cervagème | gemeprost | gemeprost, (2e,11alpha,13e,15r)-isomer | nourypharm brand of gemeprost | ono 802 | ono-802 | pg802 | sc-37681

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (3)


 

Abortion, Incomplete (Phase 2)

Abortion, Induced (Phase 2)

Abortion, Missed (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue